Anaplastic large cell lymphoma associated with breast implants: A report of 13 cases

American Journal of Surgical Pathology

Volumn 36, Issue 7, 2012, Pages 1000-1008

  Aladily, Tariq N ^a   Medeiros, L Jeffrey ^a   Amin, Mitual B ^b   Haideri, Nisreen ^c   Ye, Dongjiu ^d   Azevedo, Sergio J ^e   Jorgensen, Jeffrey L ^a   De Peralta Venturina, Mariza ^f   Mustafa, Eid B ^g   Young, Ken H ^a   You, M James ^a   Fayad, Luis E ^a   Blenc, Ann Marie ^b   Miranda, Roberto N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^d Bioreference Laboratory   (United States)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f Cedars Sinai Medical Center   (United States)

^g Plastic and Reconstructive Surgery   (United States)

Author keywords

anaplastic large cell lymphoma; breast implant associated ALCL; non Hodgkin lymphoma

Indexed keywords

ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN; CD30 ANTIGEN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST AUGMENTATION; BREAST ENDOPROSTHESIS; BREAST TUMOR; CANCER STAGING; CHEMISTRY; DEVICE REMOVAL; FEMALE; GENE REARRANGEMENT; GENETICS; HUMAN; LARGE CELL LYMPHOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; T LYMPHOCYTE RECEPTOR GENE; TIME; TREATMENT OUTCOME; UNITED STATES;

ACTIVIN RECEPTORS, TYPE II; ADULT; AGED; ANTIGENS, CD30; BREAST IMPLANTATION; BREAST IMPLANTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DEVICE REMOVAL; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, T-CELL RECEPTOR DELTA; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; TEXAS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84863316196     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31825749b1     Document Type: Article

References (29)

1. US Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analyses. 2011. Available at: http://www.fda.gov/Medical Devices/ProductsandMedicalProcedures/ ImplantsandProsthetics/Br eastImplants/ucm239995.htm. Accessed June 22, 2011.
2. US Food and Drug Administration. FDA medical device communication: reports of anaplastic large cell lymphoma (ALCL) in women with breast implants. 2011. Available at: http://www. fda.gov/medicaldevices/safety/alertsandnotices/ ucm240000.htm. Accessed January 26, 2011.
3. Aladily TN, Medeiros LJ, Alayed K, et al. Breast implant-associated anaplastic large cell lymphoma: a newly recognized entity that needs further refinement of its definition. Leuk Lymphoma. 2012; 53:749-750.
4. Anonym. Revised CAP Guidelines for Prosthetic Breast Implants. CAP Today. Chicago: College of American Pathologists; 1995.
5. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the longterm follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653-3661. (Pubitemid 30412833)
6. Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009;4:11.
7. Carty MJ, Pribaz JJ, Antin JH, et al. A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg. 2011;128:112e-118e.
8. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008;300: 2030-2035.
9. Do V, Shifrin DA, Oostendorp L. Lymphoma of the breast capsule in a silicone implant-reconstructed patient. Am Surg. 2010;76:1030-1031.
10. Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer-a case report. Virchows Arch. 2006;449:561-564. (Pubitemid 44722325)
11. Gaudet G, Friedberg JW, Weng A, et al. Breast lymphoma associated with breast implants: two case-reports and a review of the literature. Leuk Lymphoma. 2002;43:115-119. (Pubitemid 34228827)
12. Gualco G, Bacchi CE. B-cell and T-cell lymphomas of the breast: clinical-pathological features of 53 cases. Int J Surg Pathol. 2008;16:407-413.
13. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100: 554-555.
14. Kenkel JM. Discussion: anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg. 2011;127:2151-2153.
15. Lazzeri D, Agostini T, Giannotti G, et al. Null-type anaplastic lymphoma kinase-negative anaplastic large cell lymphoma arising in a silicone breast implant capsule. Plast Reconstr Surg. 2011;127: 159e-162e.
16. Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma. Am J Clin Pathol. 2007;127:707-722.
17. Miranda RN. Breast implant-associated anaplastic large cell lymphoma. In: Medeiros LJ, ed. Diagnostic Pathology: Lymph Nodes and Spleen With Extranodal Lymphomas. Altona, Manitoba: Amirsys Inc.; 2011:10-12 to 10-19.
18. Miranda RN, Lin L, Talwalkar SS, et al. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med. 2009;133: 1383-1390.
19. Newman MK, Zemmel NJ, Bandak AZ, et al. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008;61:822-825. (Pubitemid 351970472)
20. Olack B, Gupta R, Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg. 2007;59:56-57. (Pubitemid 46987980)
21. Popplewell L, Thomas SH, Huang Q, et al. Primary anaplastic largecell lymphoma associated with breast implants. Leuk Lymphoma. 2011;52:1481-1487.
22. Ralfkiaer EWR, Paulli M, Kadin ME. Primary cutaneous CD30+ T-cell lymphoproliferative disorders. In: Swerdlow SHCE, Harris NL, Jaffe ES, et al, eds. Tumours of the Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:300-301.
23. Roden AC, Macon WR, Keeney GL, et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008;21:455-463. (Pubitemid 351441035)
24. Sahoo S, Rosen PP, Feddersen RM, et al. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med. 2003;127: e115-e118.
25. Talwalkar SS, Miranda RN, Valbuena JR, et al. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32:1299-1309.
26. Thompson PA, Lade S, Webster H, et al. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010;95: 1977-1979.
27. Vega F, Medeiros LJ, Jones D, et al. A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions. Am J Clin Pathol. 2001;116:17-24. (Pubitemid 32601122)
28. Westra WH, Hruban RH, Phelps TH, et al. Surgical Pathology Dissection: An Illustrated Guide. New York: Springer Verlag; 2004.
29. Zarbo RJ, Nakhleh RE. Surgical pathology specimens for gross examination only and exempt from submission: a College of American Pathologists Q-Probes study of current policies in 413 institutions. Arch Pathol Lab Med. 1999;123:133-139. (Pubitemid 29093598)